Osaic Holdings
CCCC icon

Osaic Holdings’s C4 Therapeutics CCCC Stock Holding History

Osaic Holdings’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.2K Buy
9,672
+5,128
+113% +$17.5K ﹤0.01% 5560
2026
Q1 		$11.9K Hold
4,544
– – ﹤0.01% 6190
2025
Q4 		$8.68K Buy
4,544
+14
+0.3% +$33 ﹤0.01% 6429
2025
Q3 		$11.3K Buy
4,530
+3,030
+202% +$7.27K ﹤0.01% 6290
2025
Q2 		$2.15K Buy
+1,500
New +$2.18K ﹤0.01% 6913
2024
Q4 		– Sell
-530
Closed -$3.02K – 7432
2024
Q3 		$3.02K Buy
+530
New +$3.19K ﹤0.01% 6436
2023
Q4 		– Sell
-1,000
Closed -$1.86K – 7317
2023
Q3 		$1.86K Buy
+1,000
New +$3.05K ﹤0.01% 6655
2023
Q1 		– Sell
-185
Closed -$1K – 7505
2022
Q4 		$1K Buy
+185
New +$1.53K ﹤0.01% 6845

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Osaic Holdings's CCCC Position: Q2 2026 in Review

Osaic Holdings increased its C4 Therapeutics (CCCC) stake by 113% in Q2 2026, buying an estimated $17.5K and bringing the position to 9,672 shares worth $45.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5560.

Osaic Holdings first reported a position in CCCC in Q4 2022 and has held it in 8 quarters since. 147 funds tracked by Wall St. Rank hold CCCC as of Q2 2026.

  • Osaic Holdings held 9,672 shares of C4 Therapeutics worth $45.2K as of Q2 2026.
  • Osaic Holdings bought 5,128 C4 Therapeutics shares in Q2 2026, an estimated $17.5K.
  • C4 Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5560 holding.
  • Osaic Holdings first reported a position in C4 Therapeutics in Q4 2022 and has held it in 8 quarters since.
  • 147 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.